GL1X · GenesisL1 explorer

Research workbench

Crystal structure of crenezumab Fab

Analyse Crystal structure of crenezumab Fab in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
5VZX
Type
protein
Length
865 residues
Chains
4
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
UniProt
P0DOX5, Q0KKI6
Ligands
SO4

Structure

x-ray diffraction · 3 distinct chains.

ChainMoleculeTypeResiduesSecondary structureUniProt
H, E—protein214—P0DOX5
L—protein218—Q0KKI6
I—protein219—Q0KKI6

Ligands and binding sites

  • SO4 · Sulfate ion · ion · 11 copies · chains H, L, E, I
  • MES · 2-(N-morpholino)-ethanesulfonic acid · additive · 2 copies · chains H, L, E, I
  • EPE · 4-(2-hydroxyethyl)-1-piperazine ethanesulfonic acid · additive · 2 copies · chains L, I

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Compared structures

  • 5VZX · Crystal structure of crenezumab Fab · the same entry in another collection · chain H against H, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.